M C Schielein1,2, L Tizek3,4, F Seifert5, T Biedermann3, A Zink6. 1. Technische Universität München, Fakultät für Medizin, Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, München, Deutschland. maximilian.schielein@tum.de. 2. Ludwig-Maximilians-Universität München, Institut für Medizinische Informationsverarbeitung Biometrie und Epidemiologie (IBE), München, Deutschland. maximilian.schielein@tum.de. 3. Technische Universität München, Fakultät für Medizin, Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, München, Deutschland. 4. Ludwig-Maximilians-Universität München, Institut für Medizinische Informationsverarbeitung Biometrie und Epidemiologie (IBE), München, Deutschland. 5. Hautarzt Oberland, Gmund, Deutschland. 6. Technische Universität München, Fakultät für Medizin, Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, München, Deutschland. alexander.zink@tum.de.
Abstract
BACKGROUND: Psoriasis, atopic eczema and urticaria are chronic inflammatory skin diseases that are often associated with an impairment of affected individuals and their families. Despite constant progress in therapy of these diseases, affected people often do not consult an office-based dermatologist. OBJECTIVES: The aim of this study was to estimate which proportion of affected individuals with severe forms of these diseases receive treatment by an office-based dermatologist in Bavaria. MATERIALS AND METHODS: All dermatologists listed in the database of the Bavarian Association of Panel Doctors (KVB; Kassenärztliche Vereinigung Bayern; n = 499) were invited to participate in a paper-based cross-sectional study. The stated number of patients by each dermatologist were set in relation with the literature-based 1‑year prevalence, as well as data on population and data of the KVB. Estimations were based on three approaches (conservative, medium, and progressive estimation method). RESULTS: Overall, 137 dermatologists participated (38.7% women; mean age: 53.2 ± 8.5 years). Conservative estimation indicated that 56.5% of individuals with moderate to severe psoriasis, 57.3% of individuals with moderate to severe atopic eczema and 71.9% of those suffering from chronic spontaneous urticaria are not seen by an office-based dermatologist. CONCLUSION: Many affected individuals seem not to seek an office-based dermatologist when affected by a severe skin condition. Thus, further and more precise studies to identify, address and minimize barriers to optimal patient care are needed.
BACKGROUND:Psoriasis, atopic eczema and urticaria are chronic inflammatory skin diseases that are often associated with an impairment of affected individuals and their families. Despite constant progress in therapy of these diseases, affected people often do not consult an office-based dermatologist. OBJECTIVES: The aim of this study was to estimate which proportion of affected individuals with severe forms of these diseases receive treatment by an office-based dermatologist in Bavaria. MATERIALS AND METHODS: All dermatologists listed in the database of the Bavarian Association of Panel Doctors (KVB; Kassenärztliche Vereinigung Bayern; n = 499) were invited to participate in a paper-based cross-sectional study. The stated number of patients by each dermatologist were set in relation with the literature-based 1‑year prevalence, as well as data on population and data of the KVB. Estimations were based on three approaches (conservative, medium, and progressive estimation method). RESULTS: Overall, 137 dermatologists participated (38.7% women; mean age: 53.2 ± 8.5 years). Conservative estimation indicated that 56.5% of individuals with moderate to severe psoriasis, 57.3% of individuals with moderate to severe atopic eczema and 71.9% of those suffering from chronic spontaneous urticaria are not seen by an office-based dermatologist. CONCLUSION: Many affected individuals seem not to seek an office-based dermatologist when affected by a severe skin condition. Thus, further and more precise studies to identify, address and minimize barriers to optimal patient care are needed.
Entities:
Keywords:
Atopic eczema; Health service research; Patient-centered care; Psoriasis; Urticaria
Authors: Thomas Werfel; Werner Aberer; Frank Ahrens; Matthias Augustin; Tilo Biedermann; Thomas Diepgen; Regina Fölster-Holst; Uwe Gieler; Annice Heratizadeh; Julia Kahle; Alexander Kapp; Alexander Nast; Katja Nemat; Hagen Ott; Bernhard Przybilla; Martin Roecken; Martin Schlaeger; Peter Schmid-Grendelmeier; Jochen Schmitt; Thomas Schwennesen; Doris Staab; Margitta Worm Journal: J Dtsch Dermatol Ges Date: 2016-01 Impact factor: 5.584
Authors: Matthias Augustin; Christina Spehr; Marc A Radtke; Wolf-Henning Boehncke; Thomas Luger; Ulrich Mrowietz; Michael Reusch; Klaus Strömer; Gottfried Wozel; Ralph von Kiedrowski; Stephan J Rustenbach; Sandra Purwins; Kristian Reich Journal: J Dtsch Dermatol Ges Date: 2014-01 Impact factor: 5.584
Authors: J Ring; A Zink; B W M Arents; I A Seitz; U Mensing; M C Schielein; N Wettemann; G de Carlo; A Fink-Wagner Journal: J Eur Acad Dermatol Venereol Date: 2019-06-06 Impact factor: 6.166
Authors: Helen Nankervis; Alison Devine; Hywel C Williams; John R Ingram; Elizabeth Doney; Finola Delamere; Sherie Smith; Kim S Thomas Journal: BMC Dermatol Date: 2015-03-14
Authors: M Maurer; M Abuzakouk; F Bérard; W Canonica; H Oude Elberink; A Giménez-Arnau; C Grattan; K Hollis; A Knulst; J-P Lacour; C Lynde; A Marsland; D McBride; A Nakonechna; J Ortiz de Frutos; C Proctor; G Sussman; C Sweeney; H Tian; K Weller; D Wolin; M-M Balp Journal: Allergy Date: 2017-07-10 Impact factor: 13.146
Authors: Maximilian Christian Schielein; Linda Tizek; Barbara Schuster; Stefanie Ziehfreund; Tilo Biedermann; Alexander Zink Journal: Acta Derm Venereol Date: 2020-05-28 Impact factor: 3.875
Authors: Maximilian Christian Schielein; Linda Tizek; Barbara Schuster; Stefanie Ziehfreund; Claudia Liebram; Kilian Eyerich; Alexander Zink Journal: J Clin Med Date: 2020-06-11 Impact factor: 4.241